Skip to content

Bills · 2017-2018 Regular Session

AB 69

Died at session end Official bill text Atom feed

Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.

Death Drugs Medical malpractice Medical service Physician United states — Food and drug administration

  1. Introduced, stopped here
  2. Passes Assembly, not reached
  3. Passes Senate, not reached
  4. Governor signs, not reached
  5. Law, not reached

Unfamiliar terms? Glossary

What this bill does

Plain-language analysis by the nonpartisan Legislative Reference Bureau

Under this bill, a manufacturer of an investigational drug, device, or biological

product may make the investigational drug, device, or biological product available

to an eligible patient. Under the bill, an investigational drug, device, or biological

product is one that has not yet been approved for use by the federal Food and Drug

Administration, but, among other requirements, has successfully completed a phase

one clinical trial and remains under investigation or is pending approval by the FDA.

A patient is eligible under the bill if, among other things, the patient has considered

all other available treatment options, has received a treating physician's

recommendation or prescription order for an investigational drug, device, or

biological product, and has given written informed consent for use of the

investigational drug, device, or biological product.

The bill provides a limitation of liability under state law for a manufacturer,

distributor, pharmacist, physician or other practitioner, or other person who makes

available, delivers, distributes, prescribes, dispenses, or administers an

investigational drug, device, or biological product to an eligible patient consistent

with the bill's provisions, and who in doing so exercises reasonable care.

Finally, the bill prohibits an official, employee, or agent of the state from

blocking or attempting to block an eligible patient's access to an investigational drug,

device, or biological product.

Sponsors

Introduced by: Allen (R) , Anderson (D) , Ballweg (R) , Berceau (D) , Bernier (R) , Brandtjen (R) , C. Taylor (D) , Doyle (D) , E. Brooks (R) , Edming (R) , Gannon (R) , Hesselbein (D) , Horlacher (R) , Hutton (R) , Jagler (R) , Katsma (R) , Kleefisch (R) , Knodl (R) , Kooyenga (R) , Kremer (R) , Krug (R) , Kulp (R) , Loudenbeck (R) , Mason (D) , Milroy (D) , Murphy (R) , Mursau (R) , Novak (R) , Pope (D) , Quinn (R) , R. Brooks (R) , Ripp (R) , Sargent (D) , Sinicki (D) , Skowronski (R) , Snyder (R) , Spiros (R) , Steffen (R) , Subeck (D) , Tauchen (R) , Tittl (R) , Tusler (R) , VanderMeer (R) , Vruwink (D)

18 cosponsors

Carpenter (D) , Cowles (R) , Craig (R) , Darling (R) , Feyen (R) , Harsdorf (R) , Johnson (D) , Kapenga (R) , L. Taylor (D) , Lasee (R) , LeMahieu (R) , Marklein (R) , Miller (D) , Moulton (R) , Petrowski (R) , Risser (D) , Thiesfeldt, Petryk, Petersen, Summerfield, Ott, Kitchens, Macco, Rohrkaste and Duchow , Vinehout (D)

Votes

Assembly: Report Assembly Substitute Amendment 1 adoption recommended by Committee on Health, Ayes 10, Noes 2

Passed 10–2 Mar 1, 2017 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Assembly: Report passage as amended recommended by Committee on Health, Ayes 10, Noes 2

Passed 10–2 Mar 1, 2017 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Assembly: Assembly Amendment 3 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

Passed 64–34 Mar 7, 2017 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Assembly: Assembly Amendment 4 to Assembly Substitute Amendment 1 laid on table, Ayes 65, Noes 33

Passed 65–33 Mar 7, 2017 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Assembly: Assembly Amendment 5 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

Passed 64–34 Mar 7, 2017 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Assembly: Assembly Amendment 6 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

Passed 64–34 Mar 7, 2017 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Assembly: PASSAGE

Passed 85–13 Mar 7, 2017 official source full page

Aye · 85

Not voting · 1

Full history

  1. Feb 13, 2017 · Assembly

    Introduced by Representatives Snyder, Kleefisch, Hesselbein, Krug, Skowronski, Steffen, Milroy, Kremer, Brandtjen, Pope, Kooyenga, Edming, Mursau, Tittl, Sargent, Horlacher, Kulp, Mason, E. Brooks, Spiros, Bernier, C. Taylor, Vruwink, Novak, R. Brooks, VanderMeer, Jagler, Knodl, Quinn, Anderson, Ballweg, Tauchen, Berceau, Murphy, Subeck, Gannon, Sinicki, Ripp, Katsma, Allen, Doyle, Zamarripa, Tusler, Hutton and Loudenbeck; cosponsored by Senators Moulton, Risser, Carpenter, Johnson, L. Taylor, Cowles, Feyen, Lasee, Craig, Kapenga, Darling, Marklein, Miller, Petrowski, LeMahieu, Harsdorf and Vinehout

  2. Feb 13, 2017 · Assembly

    Read first time and referred to Committee on Health

  3. Feb 22, 2017 · Assembly

    Public hearing held

  4. Feb 28, 2017 · Assembly

    Assembly Amendment 1 offered by Representatives Kolste, Subeck, C. Taylor and Zamarripa

  5. Feb 28, 2017 · Assembly

    Assembly Amendment 2 offered by Representatives Kolste, Subeck, C. Taylor and Zamarripa

  6. Feb 28, 2017 · Assembly

    Assembly Amendment 3 offered by Representatives Subeck, Kolste, C. Taylor and Zamarripa

  7. Feb 28, 2017 · Assembly

    Assembly Substitute Amendment 1 offered by Representative Snyder

  8. Mar 1, 2017 · Assembly

    Report Assembly Substitute Amendment 1 adoption recommended by Committee on Health, Ayes 10, Noes 2

  9. Mar 1, 2017 · Assembly

    Report passage as amended recommended by Committee on Health, Ayes 10, Noes 2

  10. Mar 1, 2017 · Assembly

    Referred to committee on Rules

  11. Mar 1, 2017 · Assembly

    Placed on calendar 3-7-2017 by Committee on Rules

  12. Mar 1, 2017 · Assembly

    Assembly Amendment 1 to Assembly Substitute Amendment 1 offered by Representatives Kolste, Subeck, C. Taylor and Zamarripa

  13. Mar 1, 2017 · Assembly

    Assembly Amendment 2 to Assembly Substitute Amendment 1 offered by Representatives Subeck, Kolste, C. Taylor and Zamarripa

  14. Mar 1, 2017 · Assembly

    Executive action taken

  15. Mar 3, 2017 · Assembly

    Representative Zamarripa withdrawn as a coauthor

  16. Mar 7, 2017 · Assembly

    Read a second time

  17. Mar 7, 2017 · Assembly

    Assembly Amendment 3 to Assembly Substitute Amendment 1 offered by Representatives Shankland, Hesselbein, Barca, Doyle and Spreitzer

  18. Mar 7, 2017 · Assembly

    Assembly Amendment 3 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

  19. Mar 7, 2017 · Assembly

    Assembly Amendment 4 to Assembly Substitute Amendment 1 offered by Representatives Subeck, Sargent and Spreitzer

  20. Mar 7, 2017 · Assembly

    Assembly Amendment 4 to Assembly Substitute Amendment 1 laid on table, Ayes 65, Noes 33

  21. Mar 7, 2017 · Assembly

    Assembly Amendment 5 to Assembly Substitute Amendment 1 offered by Representative Shankland

  22. Mar 7, 2017 · Assembly

    Assembly Amendment 5 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

  23. Mar 7, 2017 · Assembly

    Assembly Amendment 6 to Assembly Substitute Amendment 1 offered by Representative Riemer

  24. Mar 7, 2017 · Assembly

    Assembly Amendment 6 to Assembly Substitute Amendment 1 laid on table, Ayes 64, Noes 34

  25. Mar 7, 2017 · Assembly

    Assembly Substitute Amendment 1 adopted

  26. Mar 7, 2017 · Assembly

    Ordered to a third reading

  27. Mar 7, 2017 · Assembly

    Rules suspended

  28. Mar 7, 2017 · Assembly

    Read a third time and passed, Ayes 85, Noes 13

  29. Mar 7, 2017 · Assembly

    Representatives Thiesfeldt, Petryk, Petersen, Summerfield, Ott, Kitchens, Macco, Rohrkaste and Duchow added as coauthors

  30. Mar 7, 2017 · Assembly

    Ordered immediately messaged

  31. Mar 8, 2017 · Senate

    Received from Assembly

  32. Mar 9, 2017 · Senate

    Read first time and referred to committee on Health and Human Services

  33. Aug 16, 2017 · Senate

    Public hearing held

  34. Mar 28, 2018 · Senate

    Failed to concur in pursuant to Senate Joint Resolution 1